David Fischer

机构：Ono Pharmaceutical (United States), FH Aachen

发表论文 45 篇 · 总被引 2015 次 · h-index 22

代表论文

• Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases (2013 · Nature Structural & Molecular Biology · 被引 317)
• Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties (2016 · Metabolic Engineering · 被引 121)
• De novo biosynthesis of anthocyanins in Saccharomyces cerevisiae (2018 · FEMS Yeast Research · 被引 74)
• A homogeneous high-DAR antibody–drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides (2022 · Chemical Science · 被引 64)
• Impact of Bariatric Surgery on Life Expectancy in Severely Obese Patients With Diabetes (2015 · Annals of Surgery · 被引 59)
• Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation (2012 · Hepatology · 被引 59)